Danielle Keatley | Director of Investor Relations |
Emil Kakkis | President and Chief Executive Officer |
Shalini Sharp | Chief Financial Officer. |
Eric Schmidt | Cowen and Company |
Tazeen Ahmad | Bank of America |
Joseph Schwartz | Leerink Partners |
Laura Chico | Raymond James |
Steven Breazzano | Evercore ISI |
Maury Raycroft | Jefferies |
Arlinda Lee | Canaccord Genuity |
Matthew Harrison | Morgan Stanley |
Good day, ladies and gentlemen, and welcome to the Third Quarter 2017 Financial Results and Corporate Update Conference Call.[Operator Instructions] As a reminder, this conference is being recorded. I would now like to introduce your host for today's conference, Danielle Keatley.
You may begin.
Good afternoon, and welcome to the Ultragenyx Pharmaceutical Financial Results and Corporate Update Conference Call for the Third Quarter of 2017.
We have issued a press release detailing our financial results, which you can find on our website at ultragenyx.com.